ClinicalTrials.gov
public full text
Public Domain
Pitolisant in Refractory Restless Legs Syndrome
This is an open-label trial in Restless Legs Syndrome (RLS) patients inadequately treated with standard therapy, defined by an IRLS score greater than 15. Investigators hypothesize that the study drug, Pitolisant (Wakix), may improve RLS symptoms.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD#871043
- Pain Treatment for Sciatica#905212
- The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome#1010018
- Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation#880561
- Proton Pump Inhibitor-Associated Restless Legs Syndrome.#613475
Record · ID 824837
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive